BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35587572)

  • 1. Prognosis prediction of stage IV colorectal cancer patients by mRNA transcriptional profile.
    Wu B; Yang J; Qin Z; Yang H; Shao J; Shang Y
    Cancer Med; 2022 Dec; 11(24):4900-4912. PubMed ID: 35587572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational and transcriptional alterations and clinicopathological factors predict the prognosis of stage I hepatocellular carcinoma : Prediction of stage I HCC prognosis.
    Li Z; Gao H; Zhang X; Liu Q; Chen G
    BMC Gastroenterol; 2022 Sep; 22(1):427. PubMed ID: 36153509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic features and genomic alterations of primary colorectal adenocarcinoma predict growth patterns of liver metastasis.
    Wu JB; Sarmiento AL; Fiset PO; Lazaris A; Metrakos P; Petrillo S; Gao ZH
    World J Gastroenterol; 2019 Jul; 25(26):3408-3425. PubMed ID: 31341365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis.
    Zhuang Y; Wang H; Jiang D; Li Y; Feng L; Tian C; Pu M; Wang X; Zhang J; Hu Y; Liu P
    BMC Cancer; 2021 Apr; 21(1):380. PubMed ID: 33836681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF V600E and SRC mutations as molecular markers for predicting prognosis and conversion surgery in Stage IV colorectal cancer.
    Shimada Y; Muneoka Y; Nagahashi M; Ichikawa H; Tajima Y; Hirose Y; Ando T; Nakano M; Sakata J; Kameyama H; Takii Y; Ling Y; Okuda S; Takabe K; Wakai T
    Sci Rep; 2019 Feb; 9(1):2466. PubMed ID: 30792536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
    Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
    Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases.
    Mizuno T; Cloyd JM; Vicente D; Omichi K; Chun YS; Kopetz SE; Maru D; Conrad C; Tzeng CD; Wei SH; Aloia TA; Vauthey JN
    Eur J Surg Oncol; 2018 May; 44(5):684-692. PubMed ID: 29551247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases.
    Isella C; Mellano A; Galimi F; Petti C; Capussotti L; De Simone M; Bertotti A; Medico E; Muratore A
    Ann Surg; 2013 Jun; 257(6):1089-95. PubMed ID: 23665971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases.
    Løes IM; Immervoll H; Sorbye H; Angelsen JH; Horn A; Knappskog S; Lønning PE
    Int J Cancer; 2016 Aug; 139(3):647-56. PubMed ID: 26991344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Single-organ Metastasis to the Liver or Lung and Genetic Mutation Status on Prognosis in Stage IV Colorectal Cancer.
    Cavallaro P; Bordeianou L; Stafford C; Clark J; Berger D; Cusack J; Kunitake H; Francone T; Ricciardi R
    Clin Colorectal Cancer; 2020 Mar; 19(1):e8-e17. PubMed ID: 31899147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated tumor-to-liver uptake ratio (TLR) from
    Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of KRAS and BRAF in stage I-III colorectal cancer. A systematic review.
    Gallo G; Sena G; Vescio G; Papandrea M; Sacco R; Trompetto M; Sammarco G
    Ann Ital Chir; 2019; 90():127-137. PubMed ID: 30739887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation Spectra of Common Cancer-Associated Genes in Different Phenotypes of Colorectal Carcinoma Without Distant Metastasis.
    Chang SC; Lin PC; Lin JK; Lin CH; Yang SH; Liang WY; Chen WS; Jiang JK
    Ann Surg Oncol; 2016 Mar; 23(3):849-55. PubMed ID: 26471487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Factors of Colorectal Cancer: A Comparative Study on Patients With or Without Liver Metastasis.
    Peng H; Liu G; Bao Y; Zhang X; Zhou L; Huang C; Song Z; Cao S; Dang S; Zhang J; Huang T; Wu Y; Xu M; Song L; Cao P
    Front Oncol; 2021; 11():626190. PubMed ID: 34993129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.
    Pentheroudakis G; Kotoula V; De Roock W; Kouvatseas G; Papakostas P; Makatsoris T; Papamichael D; Xanthakis I; Sgouros J; Televantou D; Kafiri G; Tsamandas AC; Razis E; Galani E; Bafaloukos D; Efstratiou I; Bompolaki I; Pectasides D; Pavlidis N; Tejpar S; Fountzilas G
    BMC Cancer; 2013 Feb; 13():49. PubMed ID: 23374602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor.
    Fujiyoshi K; Yamamoto G; Takenoya T; Takahashi A; Arai Y; Yamada M; Kakuta M; Yamaguchi K; Akagi Y; Nishimura Y; Sakamoto H; Akagi K
    Anticancer Res; 2017 Jan; 37(1):239-247. PubMed ID: 28011498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel prognostic risk score model based on immune-related genes in patients with stage IV colorectal cancer.
    Xu K; He J; Zhang J; Liu T; Yang F; Ren T
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33034614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational and Transcriptional Characterization Establishes Prognostic Models for Resectable Lung Squamous Cell Carcinoma.
    Liu Y; Duan J; Zhang F; Liu F; Luo X; Shi Y; Lei Y
    Cancer Manag Res; 2023; 15():147-163. PubMed ID: 36824152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection.
    Molleví DG; Serrano T; Ginestà MM; Valls J; Torras J; Navarro M; Ramos E; Germà JR; Jaurrieta E; Moreno V; Figueras J; Capellà G; Villanueva A
    Carcinogenesis; 2007 Jun; 28(6):1241-6. PubMed ID: 17259658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SMAD4 and TS expression might predict the risk of recurrence after resection of colorectal liver metastases.
    López-Gómez M; Moreno-Rubio J; Suárez-García I; Cejas P; Madero R; Casado E; Jiménez A; Sereno M; Gómez-Raposo C; Zambrana F; Merino M; Fernández-Luengas D; Feliu J
    Clin Transl Oncol; 2015 Feb; 17(2):133-8. PubMed ID: 25060566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.